Pearson plc
PSORF
$15.57
-$0.68-4.19%
| Weiss Ratings | PSORF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Good | |||
| Risk Index | Good | |||
| Risk Grade | B+ | |||
| Reward Grade | B+ | |||
| Rating Factors | PSORF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | Weak | |||
| Growth Index | Good | |||
| Efficiency Index | Good | |||
| Solvency Index | Good | |||
| Total Return Index | Good | |||
| Volatility Index | Good | |||
| Beta / Standard Deviation | PSORF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.05 | |||
| Price History | PSORF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -8.52% | |||
| 30-Day Total Return | -3.69% | |||
| 60-Day Total Return | 6.28% | |||
| 90-Day Total Return | 22.60% | |||
| Year to Date Total Return | -3.69% | |||
| 1-Year Total Return | 20.52% | |||
| 2-Year Total Return | 57.43% | |||
| 3-Year Total Return | 59.19% | |||
| 5-Year Total Return | 139.02% | |||
| 52-Week High % Change | -9.29% | |||
| 52-Week Low % Change | 31.95% | |||
| Price | PSORF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $17.17 | |||
| 52-Week Low Price | $11.80 | |||
| 52-Week Low Price (Date) | Apr 15, 2024 | |||
| 52-Week High Price (Date) | Feb 28, 2025 | |||
| Valuation | PSORF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 10.82B | |||
| Enterprise Value | 12.12B | |||
| Price/Earnings (TTM) | 24.93 | |||
| Earnings Per Share (TTM) | 0.62 | |||
| Earnings Per Share Growth | 27.70% | |||
| Price/Earnings To Growth | 0.90 | |||
| Price/Sales (TTM) | 2.39 | |||
| Price/Book (Q) | 2.21 | |||
| Enterprise Value/Revenue (TTM) | 2.74 | |||
| Price | $15.57 | |||
| Enterprise Value/EBITDA (TTM) | 15.08 | |||
| Enterprise Value/EBIT | 17.63 | |||
| Market Cap Category | Large Cap | |||
| Dividends and Shares | PSORF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 687.40M | |||
| Dividend Yield | 0.48% | |||
| Div. Per Share (Most Recent) | $0.07 | |||
| Dividend Per Share (TTM) | $0.07 | |||
| Payout Ratio (TTM) | 44.50% | |||
| Dividend Per Share (Most Recent) | $0.07 | |||
| Company Info | PSORF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 44 20 7010 2000 | |||
| Address | -- | |||
| Website | plc.pearson.com/en-GB | |||
| Country | United Kingdom | |||
| Year Founded | 1844 | |||
| Profitability | PSORF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | 15.51% | |||
| Profit Margin | 9.83% | |||
| Management Effectiveness | PSORF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | 5.03% | |||
| Return on Equity | 8.72% | |||
| Income Statement | PSORF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 4.47B | |||
| Total Revenue (TTM) | 4.47B | |||
| Revenue Per Share | $6.50 | |||
| Gross Profit (TTM) | 2.26B | |||
| EBITDA (TTM) | 810.82M | |||
| EBIT (TTM) | 693.54M | |||
| Net Income (TTM) | 439.37M | |||
| Net Income Avl. to Common (TTM) | 439.37M | |||
| Total Revenue Growth (Q YOY) | -5.92% | |||
| Earnings Growth (Q YOY) | -14.85% | |||
| EPS Diluted (TTM) | 0.62 | |||
| EPS Diluted Growth (Q YOY) | -11.29% | |||
| Balance Sheet | PSORF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 419.58M | |||
| Cash Per Share (Q) | $0.61 | |||
| Total Current Assets (Q) | 3.19B | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 4.82B | |||
| Current Ratio (Q) | 1.778 | |||
| Book Value Per Share (Q) | $7.05 | |||
| Total Assets (Q) | 8.48B | |||
| Total Current Liabilities (Q) | 1.79B | |||
| Total Debt (Q) | 2.10B | |||
| Total Liabilities (Q) | 3.66B | |||
| Total Common Equity (Q) | 4.80B | |||
| Cash Flow | PSORF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -173.93M | |||
| Cash from Financing (TTM) | -580.29M | |||
| Net Change in Cash (TTM) | -19.82M | |||
| Levered Free Cash Flow (TTM) | 880.13M | |||
| Cash from Operations (TTM) | 736.98M | |||
